Witnessing the stock’s movement on the chart, on Wednesday, Repare Therapeutics Inc (NASDAQ: RPTX) set off with pace as it heaved 17.51% to $2.55, before settling in for the price of $2.17 at the close. Taking a more long-term approach, RPTX posted a 52-week range of $0.89-$2.30.
The Healthcare sector firm’s twelve-monthly sales growth has been -21.89% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -21.89%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 13.50%. This publicly-traded company’s shares outstanding now amounts to $42.99 million, simultaneously with a float of $34.63 million. The organization now has a market capitalization sitting at $109.93 million. At the time of writing, stock’s 50-day Moving Average stood at $2.01, while the 200-day Moving Average is $1.59.
Repare Therapeutics Inc (RPTX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Repare Therapeutics Inc’s current insider ownership accounts for 19.67%, in contrast to 37.15% institutional ownership. According to the most recent insider trade that took place on Mar 12 ’25, this organization’s EVP, CHIEF MEDICAL OFFICER sold 3,596 shares at the rate of 1.14, making the entire transaction reach 4,099 in total value, affecting insider ownership by 227,813. Preceding that transaction, on Mar 12 ’25, Company’s EVP, CHIEF SCIENTIFIC OFFICER sold 5,611 for 1.14, making the whole transaction’s value amount to 6,397. This particular insider is now the holder of 80,297 in total.
Repare Therapeutics Inc (RPTX) Earnings and Revenue Records
Repare Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 13.50% and is forecasted to reach -1.26 in the upcoming year.
Repare Therapeutics Inc (NASDAQ: RPTX) Trading Performance Indicators
Let’s observe the current performance indicators for Repare Therapeutics Inc (RPTX). It’s Quick Ratio in the last reported quarter now stands at 10.71. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.26.
In the same vein, RPTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.69, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.26 at the market close of one year from today.
Technical Analysis of Repare Therapeutics Inc (RPTX)
Going through the that latest performance of [Repare Therapeutics Inc, RPTX]. Its last 5-days volume of 3.43 million indicated improvement to the volume of 0.42 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 57.37% While, its Average True Range was 78.36.
Raw Stochastic average of Repare Therapeutics Inc (RPTX) in the period of the previous 100 days is set at 90.68%, which indicates a major rise in contrast to 79.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.06 that was lower than 0.07 volatility it exhibited in the past 100-days period.
